Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000066.xml
Rofo 2014; 186(07): E1
DOI: 10.1055/s-0035-1553365
DOI: 10.1055/s-0035-1553365
Erratum
Application of Extracellular Gadolinium-based MRI Contrast Agents and the Risk of Nephrogenic Systemic Fibrosis
Anwendung von extrazellulären gadoliniumhaltigen MR-Kontrastmitteln und Risiko der Nephrogenen Systemischen FibroseFurther Information
Correspondence
Herr Prof. Johannes T. Heverhagen
University Institute for Diagnostic, Interventional and Pediatric Radiology, Inselspital – University Hospital Bern
Freiburgstr. 10
3010 Bern
Switzerland
Phone: ++ 41/31/6 32 26 48
Fax: ++ 41/31/6 32 48 74
Email: Johannes.Heverhagen@insel.ch
Publication History
Publication Date:
02 July 2015 (online)
Erratum (2.7.2015) to: “Application of Extracellular Gadolinium-based MRI Contrast Agents and the Risk of Nephrogenic Systemic Fibrosis. Heverhagen JT et al. Fortschr Röntgenstr 2014; 186: 661 – 669”
We apologize for a translation error in the English version of this article. The sentence “The result is the following groups: gadopentetate dimeglumine, gadodiamide, gadoversetamide belong to Group I “Agents associated with the greatest number of NSF cases; (...)” was corrected with the correct term “gadopentetate”.”
#
#
Correspondence
Herr Prof. Johannes T. Heverhagen
University Institute for Diagnostic, Interventional and Pediatric Radiology, Inselspital – University Hospital Bern
Freiburgstr. 10
3010 Bern
Switzerland
Phone: ++ 41/31/6 32 26 48
Fax: ++ 41/31/6 32 48 74
Email: Johannes.Heverhagen@insel.ch